ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2,1,Hepatitis A antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3,1,Anti factor IX antibody positive,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
6,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
7,1,Embolism arterial,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
8,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
9,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
9,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
10,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
10,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
11,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
12,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
12,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,2,Anti factor IX antibody positive,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Hepatitis A,Hepatitis virus infections,Viral infectious disorders,Infec,N
15,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
15,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
16,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
17,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
19,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
19,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
19,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,2,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
20,3,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
20,4,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
22,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
22,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
22,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
24,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
25,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
25,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
25,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
26,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
27,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
27,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
28,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
29,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
29,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
29,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
29,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
30,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Activated partial thromboplastin time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
30,3,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
30,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
30,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,7,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
30,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
31,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
32,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
32,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
33,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
33,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
34,2,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
34,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
35,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
35,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
36,2,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
37,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
37,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
37,3,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
37,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
38,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
38,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
38,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
40,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
41,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
41,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
41,7,Headache,Headaches NEC,Headaches,Nerv,N
41,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
41,9,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
41,10,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
41,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
41,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,16,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
41,17,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
41,18,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
41,19,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
42,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
44,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
44,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
45,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
46,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
46,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
46,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
46,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
48,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,2,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
50,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
51,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
52,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
52,2,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
52,3,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
53,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
53,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
54,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
55,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
55,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
55,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
55,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
55,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
55,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
55,8,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
55,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
55,10,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
57,1,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
58,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
59,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
60,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
60,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
61,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
61,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
61,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
61,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
61,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
61,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
62,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
62,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
62,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
62,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
62,5,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
62,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
63,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
63,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
63,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
66,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
66,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
66,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
66,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
66,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
68,1,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
68,2,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
68,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
69,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
70,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
71,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
72,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
73,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
73,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
73,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
73,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
74,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
75,1,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
75,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
75,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
75,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
75,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
77,1,Device related thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
78,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
78,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
78,3,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
78,5,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
78,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
79,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
79,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
79,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
80,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
81,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
81,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
83,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
84,2,Intrapericardial thrombosis,Pericardial disorders NEC,Pericardial disorders,Card,N
85,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
85,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
86,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
86,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
87,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
87,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
87,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
87,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
87,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
87,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
87,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
87,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
87,10,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
88,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
89,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
89,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
89,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
89,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
90,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
91,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
91,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
92,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
92,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
92,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
92,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
93,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
93,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
94,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
94,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
95,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,2,Exostosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
95,3,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
95,4,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
95,5,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
96,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
96,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
96,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
96,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
96,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
97,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
99,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
100,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
101,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
102,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
103,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
103,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
104,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
104,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
105,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
106,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
107,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
107,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,3,Haemophilic arthropathy,Arthropathies NEC,Joint disorders,Musc,N
108,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
108,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
108,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
109,1,Splenectomy,Lymphoid tissue therapeutic procedures,Haematological and lymphoid tissue therapeutic procedures,Surg,N
109,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
110,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
111,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
112,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
112,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
112,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,1,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
114,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
114,2,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
114,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
115,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
116,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
116,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
116,3,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
116,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
116,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
116,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
116,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
117,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
117,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
117,3,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
117,4,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
117,5,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
117,6,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
118,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
119,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
120,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
121,2,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
122,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
123,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
124,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
125,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
125,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
125,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
126,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
127,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
128,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
129,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,2,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
130,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
131,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
132,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
133,1,Factor IX inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
134,1,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
134,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
134,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
134,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
137,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
138,1,Headache,Headaches NEC,Headaches,Nerv,N
139,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
139,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
139,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
139,4,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
139,5,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
139,6,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
139,7,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
139,8,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
140,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
141,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
141,2,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
142,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
143,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
143,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
143,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
143,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
143,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
143,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
144,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
144,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
144,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
144,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
144,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
145,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
146,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
148,2,Coronary artery embolism,Coronary artery disorders NEC,Coronary artery disorders,Card,N
148,3,Embolic cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
148,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
149,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
149,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
151,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
152,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
